Key facts
- Bloom Labs’s last known valuation is $37.0M (Jun 2025).
- It has raised $11.9M; the latest was Seed Round ($9.0M) in Jun 2025.
- Notable investors include SOSV, Gaingels, gener8tor, IndieBio, Neer Venture Partners — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Bloom Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Bloom Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bloom Labs
Operator of bio-plastics and textile fibers production platform intended to create sustainable alternatives to natural and synthetic materials. The company's platform uses bio-manufacturing, advanced protein engineering, and molecular biology to transform natural waste by-products into high-performance fibers, enabling textile manufacturers to create fibers that are plush as cotton, lush as silk, and functional as polyester but are made from waste.
- Sector
- Business Products and Services (B2B)
- HQ
- New York, NY, United States
- Founded
- 2023
- Employees
- 6
- Website
- everbloom.bio/
- Ownership
- Privately Held (backing)
Bloom Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bloom Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bloom Labs in its N-PORT filings yet. We sweep new filings monthly.